Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic

NCT ID: NCT07317687

Last Updated: 2026-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-01-31

Study Completion Date

2028-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

West Virginia faces rising rates of HIV, hepatitis, and syphilis, particularly among individuals experiencing homelessness, substance use, and mental health challenges. Traditional blood-draw testing for these infections is often hindered by mistrust, logistical barriers, and delays in results. This study, conducted by the West Virginia University (WVU) Street Medicine program, evaluates a rapid, point-of-care fingerstick test for HIV, Hepatitis C, and syphilis that provides results within 10-20 minutes during mobile clinic visits. Participants may choose rapid testing, traditional blood draw (which also includes Hepatitis B screening), or decline testing. All participants will be invited to complete a brief survey about the experiences with screening methods. The goal is to assess whether rapid testing improves screening uptake, linkage to care, and patient satisfaction, ultimately reducing barriers and disease burden in high-risk populations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Testing HEPATITIS C (HCV) Syphilis Hepatitis B Virus (HBV)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants receiving fingerstick test

* Will get a quick fingerstick test for HIV, Hepatitis C, and syphilis.
* Will receive results in 10-20 minutes.
* If positive, will be offered immediate care and/or a referral.
* If positive, blood draw will be offered on site to confirm results or referred to a WVU Medicine clinic location for follow-up blood test.
* Will be invited to answer survey questions about the feelings and experiences with screening (about 15-30 minutes).

Rapid Fingerstick Test

Intervention Type DIAGNOSTIC_TEST

Fingerstick test for HIV, Hepatitis B and C, and Syphilis that gives results within 10-20 minutes

Participants receiving blood-draw test

Participants receiving blood-draw test:

* Will get a blood draw to test for HIV, Hepatitis B \& C, and syphilis
* Will receive results in approximately 3 days (via MyChart message and phone call, or in person at site)
* If positive, will be offered immediate care and/or a referral for follow-up care. • Will be invited to answer questions about the feelings and experiences with screening (about 15 minutes).

Blood Draw for lab test

Intervention Type DIAGNOSTIC_TEST

Blood draw to test for HIV, Hepatitis B \& C, and syphilis which can take up to 3 days for results

Participants who decline screening

Participants who decline screening:

• Will be invited to answer survey questions about the feelings and experiences with screening (about 15-30 minutes).

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rapid Fingerstick Test

Fingerstick test for HIV, Hepatitis B and C, and Syphilis that gives results within 10-20 minutes

Intervention Type DIAGNOSTIC_TEST

Blood Draw for lab test

Blood draw to test for HIV, Hepatitis B \& C, and syphilis which can take up to 3 days for results

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of the WVU Medicine Street Medicine team

Exclusion Criteria

* Patients under the age of 18
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

West Virginia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Madison Humerick

Assistant Professor, Department of Family Medicine - Eastern

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Madison Humerick, MD

Role: PRINCIPAL_INVESTIGATOR

West Virginia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

WVU Department of Family Medicine - Eastern Division

Harpers Ferry, West Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Madison Humerick, MD

Role: CONTACT

304-535-6343

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Madison Humerick, MD

Role: primary

304-535-6343

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2507193944

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HCV Self-testing in Georgia
NCT04961723 UNKNOWN NA